Dashboard
Manage Tickers

HOLXHOLOGIC INC

Nasdaq hologic.com


$ 74.27 $ 0.04 (0.05 %)    

Friday, 28-Jun-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 74.25
$ 74.15
$ 0.00 x 0
$ 0.00 x 0
$ 73.92 - $ 75.17
$ 64.02 - $ 82.45
2,740,742
na
17.64B
$ 0.87
$ 37.81
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-03-2024 03-30-2024 10-Q
2 02-02-2024 12-30-2023 10-Q
3 11-21-2023 09-30-2023 10-K
4 08-01-2023 07-01-2023 10-Q
5 05-02-2023 04-01-2023 10-Q
6 02-01-2023 12-31-2022 10-Q
7 11-15-2022 09-24-2022 10-K
8 07-27-2022 06-25-2022 10-Q
9 04-27-2022 03-26-2022 10-Q
10 02-02-2022 12-25-2021 10-Q
11 11-16-2021 09-25-2021 10-K
12 07-28-2021 06-26-2021 10-Q
13 04-28-2021 03-27-2021 10-Q
14 01-27-2021 12-26-2020 10-Q
15 11-17-2020 09-26-2020 10-K
16 07-29-2020 06-27-2020 10-Q
17 04-29-2020 03-28-2020 10-Q
18 01-29-2020 12-28-2019 10-Q
19 11-27-2019 09-28-2019 10-K
20 07-31-2019 06-29-2019 10-Q
21 05-01-2019 03-30-2019 10-Q
22 01-30-2019 12-29-2018 10-Q
23 11-20-2018 09-29-2018 10-K
24 07-31-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-08-2018 12-30-2017 10-Q
27 11-21-2017 09-30-2017 10-K
28 08-02-2017 07-01-2017 10-Q
29 05-10-2017 04-01-2017 10-Q
30 02-03-2017 12-31-2016 10-Q
31 11-17-2016 09-24-2016 10-K
32 07-27-2016 06-25-2016 10-Q
33 04-27-2016 03-26-2016 10-Q
34 01-27-2016 12-26-2015 10-Q
35 11-19-2015 09-26-2015 10-K
36 07-29-2015 06-27-2015 10-Q
37 04-30-2015 03-28-2015 10-Q
38 01-29-2015 12-27-2014 10-Q
39 11-20-2014 09-27-2014 10-K
40 07-31-2014 06-28-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

womens-health-focused-hologic-has-significant-capacity-for-expansion-via-ma-bullish-analyst-says
Women's Health-Focused Hologic Has Signifi...
06/27/2024 18:43:24

Stephens initiated coverage on Hologic, highlighting its strong position in women's health and molecular diagnostics. Known...

this-vertex-pharmaceuticals-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday
This Vertex Pharmaceuticals Analyst Begins...
06/27/2024 12:41:40

analyst-scoreboard-7-ratings-for-hologic
Analyst Scoreboard: 7 Ratings For Hologic
06/27/2024 12:00:25

stephens--co-initiates-coverage-on-hologic-with-overweight-rating-announces-price-target-of-87
Stephens & Co. Initiates Coverage On Holog...
06/27/2024 11:42:59

Stephens & Co. analyst Mason Carrico initiates coverage on Hologic (NASDAQ:HOLX) with a Overweight rating and announces ...

hologic-recalls-biozorb-marker-due-to-complications-with-implanted-devices
Hologic Recalls BioZorb Marker Due To Comp...
05/22/2024 17:51:04

https://www.fda.gov/medical-devices/medical-device-recalls/hologic-inc-recalls-biozorb-marker-due-complications-implanted-devices

hologic-inc-recalls-biozorb-marker-due-to-reported-complications-and-adverse-events-with-implanted-devices---fda
Hologic, Inc. Recalls Biozorb Marker Due T...
05/22/2024 17:47:36

https://www.fda.gov/medical-devices/medical-device-recalls/hologic-inc-recalls-biozorb-marker-due-complications-implanted-devices

argus-research-maintains-buy-on-hologic-raises-price-target-to-95
Argus Research Maintains Buy on Hologic, R...
05/09/2024 15:43:43

Argus Research analyst David Toung maintains Hologic (NASDAQ:HOLX) with a Buy and raises the price target from $89 to $95.

jp-morgan-maintains-overweight-on-hologic-raises-price-target-to-91
JP Morgan Maintains Overweight on Hologic,...
05/03/2024 19:42:16

JP Morgan analyst Casey Woodring maintains Hologic (NASDAQ:HOLX) with a Overweight and raises the price target from $85 to $91.

deep-dive-into-hologic-stock-analyst-perspectives-4-ratings
Deep Dive Into Hologic Stock: Analyst Pers...
05/03/2024 13:00:17

needham-reiterates-buy-on-hologic-maintains-90-price-target
Needham Reiterates Buy on Hologic, Maintai...
05/03/2024 09:39:45

Needham analyst Mike Matson reiterates Hologic (NASDAQ:HOLX) with a Buy and maintains $90 price target.

hologic-revises-fy24-adj-eps-outlook-from-397-412-to-402-412-est-403-revenue-from-399b-4065b-to-4b-405b-est-4247b
Hologic Revises FY24 Adj EPS Outlook From ...
05/02/2024 20:30:04

hologic-expects-q3-adj-eps-of-098-105-est-102-revenue-of-9925m-10075m-est-1011b
Hologic Expects Q3 Adj EPS Of $0.98-$1.05 ...
05/02/2024 20:26:29

hologic-q2-2024-adj-eps-103-beats-098-estimate-sales-1017b-beat-1002b-estimate
Hologic Q2 2024 Adj EPS $1.03 Beats $0.98 ...
05/02/2024 20:02:41

Hologic (NASDAQ:HOLX) reported quarterly Adj earnings of $1.03 per share which beat the analyst consensus estimate of $0.98 by ...

hologic-to-acquire-endomagnetics-for-approximately-310m-endomagnetics-generated-35m-in-revenue-in-2023-acquisition-expected-to-be-slightly-dilutive-to-adj-eps-in-fy24-breakeven-in-2025-and-accretive-thereafter
Hologic To Acquire Endomagnetics For Appro...
04/29/2024 20:10:13

needham-reiterates-buy-on-hologic-maintains-90-price-target
Needham Reiterates Buy on Hologic, Maintai...
04/10/2024 09:21:13

Needham analyst Mike Matson reiterates Hologic (NASDAQ:HOLX) with a Buy and maintains $90 price target.

evercore-isi-group-maintains-in-line-on-hologic-raises-price-target-to-78
Evercore ISI Group Maintains In-Line on Ho...
04/04/2024 16:44:28

Evercore ISI Group analyst Vijay Kumar maintains Hologic (NASDAQ:HOLX) with a In-Line and raises the price target from $76 t...

the-analyst-landscape-4-takes-on-hologic
The Analyst Landscape: 4 Takes On Hologic
04/03/2024 15:00:39

correction-citigroup-upgrades-hologic-to-buy-raises-price-target-to-95---rating-change-updated
CORRECTION: Citigroup Upgrades Hologic to ...
04/03/2024 14:49:31

CORRECTION: Citigroup analyst Patrick Donnelly upgrades Hologic (NASDAQ:HOLX) from Neutral to Buy and raises the price target f...

citigroup-maintains-neutral-on-hologic-raises-price-target-to-95
Citigroup Maintains Neutral on Hologic, Ra...
04/03/2024 14:28:28

Citigroup analyst Patrick Donnelly maintains Hologic (NASDAQ:HOLX) with a Neutral and raises the price target from $80 to $95.

hologic-published-results-suggest-proportion-of-early-stage-hr-breast-cancer-survivors-may-be-over--or-undertreated-without-breast-cancer-index-genomic-testing
Hologic Published Results Suggest Proporti...
03/05/2024 13:12:21

Results From a Large-Scale Prospective Study Investigating Long-Term Anti-Estrogen Therapy Recommendations Published in JNCCN —...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)